Enterprise AI Analysis
Evaluating Causal Discovery Algorithms for Path-Specific Fairness and Utility in Healthcare
This comprehensive analysis delves into the critical challenges of evaluating causal discovery algorithms in healthcare, particularly when ground truth is unknown. We explore expert-defined benchmarks, path-specific fairness decomposition, and the fairness-utility trade-off, offering insights for deploying advanced AI in clinical applications.
Executive Impact: Key Performance & Fairness Insights
Our analysis uncovers critical performance metrics and fairness implications of causal discovery algorithms, vital for strategic decision-making in healthcare AI.
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Causal Discovery for Fairness & Utility in Healthcare
Determining which causal pathways drive disparity in health outcomes is a critical task in informatics for goals including targeting interventions, assessing comparative fairness of prediction models, and deciding which effects are legally or ethically permissible to adjust. Disparities can arise through direct effects of protected attributes on outcomes, indirect effects mediated by clinical variables, or spurious effects from confounders. Causal fairness frameworks decompose total variation into direct, indirect, and spurious components, enabling a nuanced understanding of which pathways contribute to disparity. One challenge is that a known causal graph is required to identify which variables act as mediators and which as confounders. Causal discovery algorithms learn graph structure from observational data, yet evaluating whether discovered graphs support reliable path-specific fairness analysis in clinical settings remains an open question.
Our framework addresses this gap by establishing expert-defined benchmarks and evaluating causal discovery for path-specific fairness on both synthetic and real-world clinical data. We used synthetically generated Alzheimer's disease data with a known structural causal model and real-world heart failure clinical records data with an expert-defined graph. For evaluation, we employed standard structural recovery metrics (F1, SHD, FDR, TPR, FPR) and advanced causal fairness metrics (Ctf-DE, Ctf-IE, Ctf-SE), alongside the Causal Fairness Utility Ratio (CFUR) to quantify the trade-off between fairness gain and accuracy loss per path.
Proposed Discovery and Evaluation Framework
Alzheimer's Disease Ground Truth Graph Overview
For the Alzheimer's disease dataset, a ground truth causal graph (Figure 2 in the original paper) was derived from a known structural causal model. This graph illustrates causal relationships between variables such as sex (protected attribute), education, age, APOE4, MOCA, AV45, tau, brain volume, and ventricular volume (outcome), including mediators and confounders. This expert-defined benchmark serves as the basis for evaluating causal discovery algorithms.
| Algorithm | F1 | SHD | FDR | TPR | FPR |
|---|---|---|---|---|---|
| PC (Fisher-Z) | 0.50 | 13 | 0.27 | 0.52 | 0.12 |
| GES (BIC) | 0.42 | 16 | 0.53 | 0.38 | 0.26 |
| NOTEARS | 0.42 | 18 | 0.40 | 0.43 | 0.53 |
| DAGMA | 0.26 | 18 | 0.60 | 0.19 | 0.18 |
| DAG-GNN | 0.13 | 20 | 0.82 | 0.10 | 0.26 |
PC (Fisher-Z) achieved the best structural recovery on the Alzheimer's dataset with an F1 score of 0.50 and the lowest Structural Hamming Distance (SHD) of 13. Continuous-optimization methods like DAG-GNN performed poorly.
The ground truth decomposition of total variation in Alzheimer's disease showed a direct effect (Ctf-DE) of 0.108, highlighting its primary contribution to disparity.
| Algorithm | Ctf-DE | Ctf-IE | Ctf-SE |
|---|---|---|---|
| Ground truth | 0.108 | -0.025 | 0.028 |
| PC | 0.105 | 0.000 | 0.000 |
| GES | 0.105 | 0.000 | 0.000 |
Discovered graphs from PC and GES collapsed the fairness decomposition to direct effect only, showing Ctf-IE and Ctf-SE as zero. This indicates structural misspecification by these algorithms regarding indirect and spurious pathways.
| Variable | Contribution (%) |
|---|---|
| education | +2.31 |
| age | +0.27 |
| apoe4 | +3.97 |
| av45 | -12.28 |
| tau | -7.66 |
For the ground truth graph, 'apoe4' was the largest positive contributor to spurious effect, while 'av45' and 'tau' showed significant negative contributions.
| Algorithm | CFUR DE | CFUR IE | CFUR SE |
|---|---|---|---|
| Ground truth | +15.5 ± 9.1 | -1.8 ± 8.0 | -0.2 ± 0.1 |
| PC | +48.5 ± 40.0 | +0.6 ± 1.6 | -0.1 ± 0.1 |
| GES | +342 ± 676 | +0.4 ± 1.6 | +1.7 ± 6.7 |
| NOTEARS | +5.7 ± 4.4 | -0.3 ± 0.3 | +8.6 ± 15.3 |
| DAGMA | +3.0 ± 1.3 | -0.0 ± 1.8 | -1.0 ± 2.3 |
Blocking the direct sex to ventricular volume path yielded the most fairness gain per unit accuracy cost across algorithms. Spurious effect (SE) generally showed negative CFUR, suggesting interventions on confounder paths increased loss with little fairness benefit.
Heart Failure Clinical Records Ground Truth Graph Overview
For the heart failure clinical records dataset, a benchmark causal graph (Figure 3 in the original paper) was established through collaboration with a domain expert and extensive literature review. This graph captures complex interdependencies between demographic variables (age, gender), comorbidities (anaemia, diabetes, hypertension, smoking), physiological measurements (serum creatinine, ejection fraction), and the mortality outcome. It serves as a crucial benchmark for evaluating causal discovery algorithms in a real-world clinical context.
| Algorithm | F1 | SHD | FDR | TPR |
|---|---|---|---|---|
| FCI | 0.38 | 20 | 0.45 | 0.29 |
| PC (Fisher-Z) | 0.18 | 24 | 0.75 | 0.14 |
| GES (BIC) | 0.16 | 25 | 0.81 | 0.14 |
FCI achieved the best structural recovery on the HFCR dataset with an F1 score of 0.38 and a lowest SHD of 20, recovering more true edges with fewer false positives compared to PC and GES.
FCI exhibited the largest spurious contribution (Ctf-SE) among algorithms for heart failure, indicating its ability to recover complex latent confounder structures.
| Graph | TV | Ctf-DE | Ctf-IE | Ctf-SE |
|---|---|---|---|---|
| Ground truth | -0.42 | -5.11 | 0.06 | -4.75 |
| PC | -0.42 | -0.42 | 0.00 | 0.00 |
| GES | -0.42 | -4.90 | 2.00 | -6.48 |
| FCI | -0.42 | -4.91 | 2.49 | -6.97 |
Total variation (TV) was consistent across graphs at approximately -0.4%. FCI and GES successfully recovered indirect and spurious components, whereas PC collapsed to direct effect only.
| Effect | Variable | Contribution (%) |
|---|---|---|
| Ctf-SE | age | +1.04 |
| Ctf-SE | platelets | +0.39 |
| Ctf-SE | serum sodium | +0.38 |
| Ctf-IE | ejection fraction | +3.37 |
| Ctf-IE | cpk | +0.85 |
| Ctf-IE | high blood pressure | +0.29 |
Ejection fraction was the most significant contributor to Ctf-IE at 3.37%, highlighting its mediating role. Age, platelets, and serum sodium contributed to Ctf-SE.
| Graph | CFUR DE | CFUR IE | CFUR SE |
|---|---|---|---|
| Ground truth | -3.8 ± 3.2 | +10.0 ± 27.5 | +0.13 ± 0.26 |
| PC | -4.0 ± 8.8 | -0.9 ± 3.1 | +0.09 ± 0.30 |
| GES | -10.6 ± 23.1 | +6.3 ± 8.9 | +0.07 ± 0.25 |
| FCI | -16.9 ± 40.1 | +0.9 ± 1.2 | +0.22 ± 0.16 |
Under the ground truth, indirect and spurious effects showed positive CFUR, suggesting potential benefits from interventions on mediators and confounders. FCI had the most negative direct-effect CFUR.
Key Insights from Discussion
Our study demonstrated that graph choice significantly influences fairness decomposition. Discovered graphs often collapse indirect and spurious components or recover them with varying fidelity. For instance, PC often reduced decomposition to direct effects only, while GES and FCI showed better recovery of indirect and spurious components, particularly FCI on the heart failure dataset due to its ability to handle latent confounders. The Causal Fairness Utility Ratio (CFUR) profiles varied by graph and dataset, providing fine-grained insights into the fairness-utility trade-off.
The findings highlight the critical need for graph-aware fairness evaluation and path-specific analysis in clinical applications. Limitations include relying on expert-defined ground truths, potential violations of faithfulness and Markov equivalence with observational data, and the sample size of the HFCR dataset impacting confidence intervals. Future work will focus on expanding the suite of causal discovery algorithms, datasets, and evaluation metrics, developing methods for multiple protected attributes, and extending the framework to broader health data domains.
Impact of Graph-Aware Fairness in Healthcare AI
This research pioneers the integration of causal discovery with path-specific fairness analysis in healthcare. By establishing expert-defined benchmarks for Alzheimer's and heart failure datasets, we've demonstrated how different causal discovery algorithms impact the decomposition of fairness into direct, indirect, and spurious effects. The Causal Fairness Utility Ratio (CFUR) offers a nuanced understanding of fairness-utility trade-offs, enabling clinicians and policymakers to prioritize interventions effectively. Our work underscores the necessity of fine-grained, graph-aware fairness evaluation to build trustworthy and equitable AI systems in clinical settings, moving beyond composite scores to actionable insights on specific causal pathways.
Challenge: Evaluating causal discovery algorithms for path-specific fairness and utility in clinical settings when ground truth is unknown.
Solution: Established expert-defined causal graph benchmarks for synthetic Alzheimer's and real-world heart failure data. Developed a pipeline to evaluate structural recovery, path-specific fairness decomposition (Ctf-DE, Ctf-IE, Ctf-SE), and fairness-utility trade-offs (CFUR) across various causal discovery algorithms (PC, GES, FCI, NOTEARS, DAGMA, DAG-GNN).
Outcome: Showed that structural recovery varies significantly across algorithms and datasets (PC best for Alzheimer's, FCI best for heart failure). Demonstrated that discovered graphs can collapse or distort indirect and spurious fairness components. Provided granular insights into variable contributions to fairness and quantified fairness-utility trade-offs per path, emphasizing the need for detailed, graph-aware evaluations.
Calculate Your Potential AI Impact
Estimate the tangible benefits of integrating advanced AI solutions into your enterprise operations.
Your AI Implementation Roadmap
A typical phased approach to integrating advanced AI, tailored for robust enterprise adoption and measurable impact.
Phase 1: Discovery & Strategy
In-depth analysis of current workflows, identification of high-impact AI opportunities, data readiness assessment, and defining a clear AI strategy aligned with business objectives.
Phase 2: Data Integration & Model Training
Secure and compliant data pipeline development, aggregation of relevant datasets, custom AI model training and fine-tuning, and initial validation for performance and fairness.
Phase 3: Pilot Deployment & Iteration
Controlled pilot implementation in a specific department or use-case, rigorous testing, collection of user feedback, and iterative model improvements based on real-world performance.
Phase 4: Full-Scale Rollout & Monitoring
Phased expansion across the enterprise, comprehensive integration with existing systems, continuous performance monitoring, and ongoing optimization for sustained value and fairness.
Ready to Transform Your Enterprise with AI?
Let's discuss how these insights apply to your specific challenges and opportunities. Our experts are ready to guide you.